Literature DB >> 27469015

Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device.

E Wilson Grandin1, Payman Zamani2, Jeremy A Mazurek2, Gregory S Troutman2, Edo Y Birati2, Esther Vorovich3, Julio A Chirinos2, Ryan J Tedford4, Kenneth B Margulies2, Pavan Atluri5, J Eduardo Rame2.   

Abstract

BACKGROUND: Right ventricular (RV) adaptation to afterload is crucial for patients undergoing continuous-flow left ventricular assist device (cf-LVAD) implantation. We hypothesized that stratifying patients by RV pulsatile load, using pulmonary arterial compliance (PAC), and RV response to load, using the ratio of central venous to pulmonary capillary wedge pressure (CVP:PCWP), would identify patients at high risk for early right heart failure (RHF) and 6-month mortality after cf-LVAD.
METHODS: During the period from January 2008 to June 2014, we identified 151 patients at our center with complete hemodynamics prior to cf-LVAD. Pulsatile load was estimated using PAC indexed to body surface area (BSA), according to the formula: indexed PAC (PACi) = [SV / (PAsystolic - PAdiastolic)] / BSA, where SV is stroke volume and PA is pulmonary artery. Patients were divided into 4 hemodynamic groups by PACi and CVP:PCWP. RHF was defined as the need for unplanned RVAD, inotropic support ≥14 days or death due to RHF within 14 days. Risk factors for RHF and 6-month mortality were examined using logistic regression and Cox proportional hazards modeling.
RESULTS: Sixty-one patients (40.4%) developed RHF and 34 patients (22.5%) died within 6 months. Patients with RHF had lower PACi (0.92 vs 1.17 ml/mm Hg/m2, p = 0.008) and higher CVP:PCWP (0.48 vs 0.37, p = 0.001). Higher PACi was associated with reduced risk of RHF (adjusted odds ratio [adj-OR] 0.61, 95% confidence interval [CI] 0.39 to 0.94, p = 0.025) and low PACi with increased risk of 6-month mortality (adjusted hazard ratio [adj-HR] 3.18, 95% CI 1.40 to 7.25, p = 0.006). Compared to patients with low load (high PACi) and adequate right heart response to load (low CVP:PCWP), patients with low PACi and high CVP:PCWP had an increased risk of RHF (OR 4.74, 95% CI 1.23 to 18.24, p = 0.02) and 6-month mortality (HR 8.68, 95% CI 2.79 to 26.99, p < 0.001).
CONCLUSIONS: A hemodynamic profile combining RV pulsatile load and response to load identifies patients at high risk for RHF and 6-month mortality after cf-LVAD.
Copyright © 2016 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LVAD; pulmonary arterial compliance; pulsatile load; right heart failure; survival

Mesh:

Year:  2016        PMID: 27469015     DOI: 10.1016/j.healun.2016.06.015

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

Review 1.  Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.

Authors:  Sriram D Rao; Jonathan N Menachem; Edo Y Birati; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2019-10

2.  Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; E Wilson Grandin; Kevin Kennedy; Fausto Cabezas; David D DeNofrio; Robb Kociol; J Eduardo Rame; Francis D Pagani; James K Kirklin; Robert L Kormos; Jeffrey Teuteberg; Michael Kiernan
Journal:  Circ Heart Fail       Date:  2019-06-11       Impact factor: 8.790

Review 3.  Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.

Authors:  Thomas C Hanff; Edo Y Birati
Journal:  Curr Heart Fail Rep       Date:  2019-10

4.  Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database.

Authors:  Chris J Kapelios; Lars H Lund; Omar Wever-Pinzon; Craig H Selzman; Susan L Myers; Ryan S Cantor; Josef Stehlik; Themistocles Chamogeorgakis; Stephen H McKellar; Antigone Koliopoulou; Rami Alharethi; Abdallah G Kfoury; Michael Bonios; Stamatis Adamopoulos; Edward M Gilbert; James C Fang; James K Kirklin; Stavros G Drakos
Journal:  Circ Heart Fail       Date:  2022-06-06       Impact factor: 10.447

Review 5.  Predicting, Recognizing, and Treating Right Heart Failure in Patients Undergoing Durable LVAD Therapy.

Authors:  Teresa S Wang; Marisa Cevasco; Edo Y Birati; Jeremy A Mazurek
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

6.  Temporary assist device support for the right ventricle: pre-implant and post-implant challenges.

Authors:  Michael Dandel; Roland Hetzer
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

7.  Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; Robin Ruthazer; David Denofrio; Amanda R Vest; David Kent; Michael S Kiernan
Journal:  J Card Fail       Date:  2021-01-12       Impact factor: 5.712

8.  Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.

Authors:  E Wilson Grandin; Gaurav Gulati; Jose I Nunez; Kevin Kennedy; J Eduardo Rame; Pavan Atluri; Francis D Pagani; James K Kirklin; Robert L Kormos; Jeffrey Teuteberg; Michael S Kiernan
Journal:  Circ Heart Fail       Date:  2022-03-25       Impact factor: 10.447

9.  Right heart failure before LVAD implantation predicts right heart failure after LVAD implantation - is it that easy?

Authors:  Tobias Wagner; Alexander M Bernhardt; Christina Magnussen; Hermann Reichenspurner; Stefan Blankenberg; Hanno Grahn
Journal:  J Cardiothorac Surg       Date:  2020-05-25       Impact factor: 1.637

10.  Noncanonical WNT Activation in Human Right Ventricular Heart Failure.

Authors:  Jonathan J Edwards; Jeffrey Brandimarto; Dong-Qing Hu; Sunhye Jeong; Nora Yucel; Li Li; Kenneth C Bedi; Shogo Wada; Danielle Murashige; Hyun Tae V Hwang; Mingming Zhao; Kenneth B Margulies; Daniel Bernstein; Sushma Reddy; Zoltan Arany
Journal:  Front Cardiovasc Med       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.